Finally, the beneficial effect of statins in blocking the TBK1-IRF3-IL-33 axis may also extend to other IL-33-dependent chronic inflammatory conditions, including chronic obstructive pulmonary disease (COPD), atopic dermatitis, and asthma104–106. Here, IRF3 is linked to atopic eczema.